Publications:

---

Understanding the activating mechanism of the immune system against COVID-19 by Traditional Indian Medicine: Network pharmacology approach.

Advances In Protein Chemistry And Structural Biology

Thirumal Kumar, D D; Shree Devi, M S MS; Udhaya Kumar, S S; Sherlin, Annie A; Mathew, Aishwarya A; Lakshmipriya, M M; Sathiyarajeswaran, P P; Gnanasambandan, R R; Siva, R R; Magesh, R R; George Priya Doss, C C

Publication Date: 2022

Variant appearance in text: ERBB2: L869Q

PubMed Link: 35305722

Variant Present in the following documents:

• mmc09-01-9780323992275.pdf

View BVdb publication page

---

Landscape of drug-resistance mutations in kinase regulatory hotspots.

Briefings In Bioinformatics

Kim, Pora P; Li, Hanyang H; Wang, Junmei J; Zhao, Zhongming Z

Publication Date: 2021-05-20

Variant appearance in text: ERBB2: L869Q

PubMed Link: 32510566

Variant Present in the following documents:

• Main text

View BVdb publication page

---

An Acquired HER2T798I Gatekeeper Mutation Induces Resistance to Neratinib in a Patient with HER2 Mutant-Driven Breast Cancer.

Cancer Discovery

Hanker, Ariella B AB; Brewer, Monica Red MR; Sheehan, Jonathan H JH; Koch, James P JP; Sliwoski, Gregory R GR; Nagy, Rebecca R; Lanman, Richard R; Berger, Michael F MF; Hyman, David M DM; Solit, David B DB; He, Jie J; Miller, Vincent V; Cutler, Richard E RE; Lalani, Alshad S AS; Cross, Darren D; Lovly, Christine M CM; Meiler, Jens J; Arteaga, Carlos L CL

Publication Date: 2017-06

Variant appearance in text: ERBB2: L869Q

PubMed Link: 28274957

Variant Present in the following documents:

• Main text

View BVdb publication page

---

ERBB2 mutations associated with solid variant of high-grade invasive lobular breast carcinomas.

Oncotarget

Deniziaut, Gabrielle G; Tille, Jean Christophe JC; Bidard, François-Clément FC; Vacher, Sophie S; Schnitzler, Anne A; Chemlali, Walid W; Trémoulet, Laurence L; Fuhrmann, Laetitia L; Cottu, Paul P; Rouzier, Roman R; Bièche, Ivan I; Vincent-Salomon, Anne A

Publication Date: 2016-11-08

Variant appearance in text: ERBB2: L869Q

PubMed Link: 27602491

Variant Present in the following documents:

• Main text
• oncotarget-07-73337.pdf

View BVdb publication page

---

Structure-functional prediction and analysis of cancer mutation effects in protein kinases.

Computational And Mathematical Methods In Medicine

Dixit, Anshuman A; Verkhivker, Gennady M GM

Publication Date: 2014

Variant appearance in text: ERBB2: L869Q

PubMed Link: 24817905

Variant Present in the following documents:

• CMMM2014-653487.pdf

View BVdb publication page

---

CanDrA: cancer-specific driver missense mutation annotation with optimized features.

Plos One

Mao, Yong Y; Chen, Han H; Liang, Han H; Meric-Bernstam, Funda F; Mills, Gordon B GB; Chen, Ken K

Publication Date: 2013

Variant appearance in text: ERBB2: L869Q

PubMed Link: 24205039

Variant Present in the following documents:

• pone.0077945.s001.xls, sheet 11

View BVdb publication page

---